Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Receivables (2023 - 2025)

Historic Receivables for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $8.3 million.

  • Profound Medical's Receivables changed N/A to $8.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year change of. This contributed to the annual value of $7.4 million for FY2024, which is 71.54% down from last year.
  • Profound Medical's Receivables amounted to $8.3 million in Q3 2025.
  • Over the past 5 years, Profound Medical's Receivables peaked at $8.3 million during Q3 2025, and registered a low of $5.1 million during Q2 2025.
  • Its 3-year average for Receivables is $6.8 million, with a median of $7.0 million in 2024.
  • In the last 5 years, Profound Medical's Receivables crashed by 71.54% in 2024 and then tumbled by 2721.52% in 2025.
  • Quarter analysis of 3 years shows Profound Medical's Receivables stood at $7.4 million in 2023, then decreased by 0.72% to $7.4 million in 2024, then rose by 12.55% to $8.3 million in 2025.
  • Its Receivables was $8.3 million in Q3 2025, compared to $5.1 million in Q2 2025 and $6.1 million in Q1 2025.